Antiviral therapy for HIV virus:  A pharmaceutical mixture encompassing  Cidofovir and Ribavirin (CR) increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene, 1/December/2017, 5.22 pm

Activation of the PD-1 pathway for Pain therapy: Glycine, a non-essential amino acid and neurotransmitter, increases the expression of PD-L1, attenuates acutes and chronic pain, and suppresses mechanical and thermal hypersensitivity and inhibits nociceptive neuron excitability via up-regulation of its target gene, 1/December/2017, 12.36 am
November 30, 2017
Molecular therapy for Stroke: Cilostazol, a phosphodiesterase inhibitor used in the treatment of Perpheral vascular disease, attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 1/December/2017, 6.44 pm
December 1, 2017
Show all

What we say:

Dr L Boominathan PhD, Director-Price 100cum-chief Scientist of GBMD, reports that: Antiviral therapy for HIV virus:  A pharmaceutical mixture encompassing  Cidofovir and Ribavirin (CR) increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene

[easy_payment currency=”USD”]


From significance of the study to Public health relevance:

Given that: (1) more than 37 million people worldwide are living with HIV/AIDS; (2) there is no effective vaccine available for HIV/AIDS; (3) HIV/AIDS tops the list of incurable diseases in humans; (4) the life-long painful drug treatment is required to treat HIV/AIDS and its associated opportunistic infections; (5) the global economic cost spent for HIV treatment is enormous, there is an urgent need to find: (i) a way to restore CD4 T-cells that were lost in HIV/AIDS; (ii) a cheaper alternative to the existing expensive antiviral drugs; (iii) a side-effect-free natural product-based drug; and (iv) a way to cure, not just treat, HIV-1/AIDS.


From research findings to Therapeutic opportunity:

This study suggests, for the first time, a small molecule-based antiviral therapy against RNA viruses such as HIV-1.

A pharmaceutical mixture encompassing Cidofovir and Ribavirin (CR), by increasing the expression of its target gene, it may increase the expression of IFN-stimulated gene-15, MX2, IFN-induced transmembrane protein 3, and Heme oxygenase-2 (HO-2)  (Figure 1). Thereby, it may: (1) bind and block the myristate moiety of HIV-1 Gag protein; (2) disrupt HIV-1 budding; (3) restrict HIV-1 infectivity, replication and production; (4) promote clearance of HIV-1 and MLV virions; and (5) strengthen antiviral immunity against RNA viruses.  Thus, pharmacological formulations encompassing “Cidofovir and Ribavirin (CR) or their analogs, either alone or in combination with other drugs” may be used to inhibit HIV-1 production.

[easy_payment currency=”USD”]

Figure 1 Mechanistic insights into how a pharmaceutical mixture encompassing Cidofovir and Ribavirin (CR) functions as an anti-HIV agent. Cidofovir and Ribavirin (CR) inhibits HIV-1 budding and production via up-regulation of HO-2

 

Figure 2. The chemical structure of Cidofovir and Ribavirin (CR). CR functions as an anti-HIV agent by inhibiting HIV-1 budding and production via up-regulation of IFN-stimulated gene-15, MX2, IFN-induced transmembrane protein 3, and HO-2.

 


Details of the research findings:

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How does a pharmaceutical mixture encompassing  Cidofovir and Ribavirin (CR) increase the expression of Heme oxygenase-2 (HO-2)?

Amount: $100#

For payment and purchase details, you may reach us at admin@genomediscovery.org

# Research cooperation


References:

Web: http://genomediscovery.org or http://newbioideas.com/

Citation: Boominathan, L.,  Antiviral therapy for HIV virus:  A pharmaceutical mixture encompassing  Cidofovir and Ribavirin (CR) increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene, 1/December/2017, 5.22 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite, drop us a line at admin@genomediscovery.org

Comments are closed.